Changes of Representative Directors and Directors (pdf 294KB)
(WorldNews Japan)

Press Release Changes of Representative Directors and Directors Tokyo, April 27, 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "the Company" ) today announced that at a meeting of its Board of Directors held today, it decided changes of Representative Directors and Directors as stated below. These changes are subject to approval at the Ordinary General Meeting of Shareholders to be held on June 19, 2017 and decision at the Board of Directors meeting scheduled for the same day. Changes of Representative Directors (New Representative Director candidate) Kenji Yasukawa (New) Representative Director, Executive Vice President (Current) Senior Corporate...